Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 18/20 | 0.62 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21551732 | 1.00 | FURIN (0.62) | FURINFFAR4 | |
| SCHEMBL21550673 | 0.90 | FURIN (0.73) | FURINFFAR4 | |
| SCHEMBL29928370 | 0.90 | FURIN (0.73) | FURINFFAR4 | |
| SCHEMBL27059020 | 0.90 | FURIN (0.48) | FURIN | |
| SCHEMBL21550794 | 0.88 | FURIN (0.56) | FURINFFAR4 | |
| SCHEMBL29928533 | 0.88 | FURIN (0.56) | FURINFFAR4 | |
| SCHEMBL29928618 | 0.86 | FURIN (0.80) | FURIN | |
| SCHEMBL21550703 | 0.86 | FURIN (0.80) | FURIN | |
| SCHEMBL21550662 | 0.85 | FURIN (0.75) | FURIN | |
| SCHEMBL29928564 | 0.85 | FURIN (0.75) | FURIN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4125897-A1 | FURIN INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS | BP Asset V, Inc. (US) | 2023-02-08 | — | — | EP | claimed |
| EP-4058021-A1 | SMALL MOLECULE FURIN INHIBITORS FOR TREATING INFECTIOUS DISEASES | BP Asset V, Inc. (US) | 2022-09-21 | — | — | EP | claimed |
| US-20230149401-A1 | FURIN INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS | BP ASSET V, INC. (US) | 2023-05-18 | — | — | US | disclosed |
| US-20230011571-A1 | SMALL MOLECULE FURIN INHIBITORS FOR TREATING INFECTIOUS DISEASES | BP ASSET V, INC. (US) | 2023-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230011571-A1 | SMALL MOLECULE FURIN INHIBITORS FOR TREATING INFECTIOUS DISEASES | FURIN, LGMN, PLAU | FURIN 1/4885FFAR4 4134/4885 |
| US-20230149401-A1 | FURIN INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS | FURIN, ACE, ACE2 | FURIN 1/4885FFAR4 4492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.